• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

    9/13/23 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email

    Provides Update on Majority Voting Policy Process

    LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web. 

    CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (CNW Group/Charlotte's Web Holdings, Inc.)" alt="Charlotte's Web (TSX:CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (CNW Group/Charlotte's Web Holdings, Inc.)">

    Mr. Morachnick is a global business executive with a track record of building premium, differentiated products and brands across multiple channels throughout the world and across a broad range of product categories. He is a proven entrepreneurial professional skilled in taking companies global and creating and managing strategies for consistent and sustained growth.  

    Mr. Morachnick was President at Santa Fe Reynolds Tobacco International (SFRTI) GmbH in Zurich, Switzerland, an international business division of Reynolds American, Inc. from 2006 to 2016. He took SFRTI from a start-up to a highly profitable organization, managing several hundred employees and a network of importers/distributors operating in Europe, Asia, and the Middle East. SFRTI was acquired by Japan Tobacco Group in 2016 for $5 billion. Mr. Morachnick led the subsequent integration of the combined companies as Chief Executive Officer and Chairman based in Tokyo, Japan for two years before returning to the U.S. in 2018.

    Since returning to the U.S. he has served as an executive advisor or board member for several companies seeking to launch and/or expand their businesses in the U.S. and overseas markets. 

    Mr. Morachnick has a Masters of Business Administration from the Thunderbird School of Global Management and is an Adjunct Professor of Global Business Strategy at the University of Nevada Las Vegas.

    "Bill has an accomplished career building businesses in multiple categories," said John Held, Chairman of Charlotte's Web. "With his proven operational expertise Bill is well-suited to take the reins to lead the Charlotte's Web team through the next phase of the Company's growth opportunities."

    The Company extends its gratitude to Mr. Tortoroli for his years of valued contributions. ‎"Jacques served on the Company's Board since November of 2019, and as CEO since late 2021 in a difficult environment devoid of regulatory oversight and clarity. Under his leadership as CEO, Jacques streamlined the organization, reduced the cash burn, and recapitalized the Company through a strategic $57 million investment from BAT (NYSE:BTI) via a convertible loan. He was instrumental in the successful launch of ReCreate™, the world's first NSF certified for Sport® broad spectrum CBD, which is the official CBD of Major League Baseball©. We are grateful to Jacques for his valuable contributions," said Mr. Held. 

    Board of Directors Majority Voting Policy Decision

    As disclosed in the Company's press release of June 16, 2023, each of John Held, Thomas Lardieri, Alicia Morga and Jacques Tortoroli did not receive the requisite majority of votes at Company's June 15, 2023 annual meeting of shareholders. In accordance with the Company's Majority Voting Policy (the "Policy"), these directors tendered offers to resign, which the Board referred to a committee of independent Board members (the "Committee") for consideration and to make a recommendation to the Board as to whether to accept the offers to resign.

    The Committee carefully considered all relevant factors and determined that there are exceptional circumstances that warrant the rejection of the offers to resign. The majority voting objectives of the Toronto Stock Exchange and the Policy are the continuous improvement of corporate governance standards through provision of a meaningful means for security holders to hold individual directors accountable. The withhold campaign launched by the activist shareholders, however, was not aligned with those objectives. The withhold campaign was instead designed to circumvent the procedures and processes in place to allow shareholders to vote based on full and complete disclosure with respect to director nominees and to make an informed decision with respect to the election of directors to the Board. Based on these principles, the Committee recommended the Board reject the offers to resign. The Board considered the Committee's recommendation along with other relevant factors, including the subject directors' significant past contributions to the Board, expertise, and integral role in stewarding the Company, and determined to reject the offers to resign.

    The Board is focused on effective corporate governance and on maximizing value for all Company stakeholders and believes that the current Board composition aligns with this objective. In accordance with its mandate, the Company's Corporate Governance and Nominating Committee regularly considers potential candidates to be considered for the Board. 

    About Charlotte's Web Holdings, Inc.

    Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is the market leader in innovative hemp extract wellness products under a family of brands that includes Charlotte's Web™, ReCreate™, CBD Medic™, and CBD Clinic™. Charlotte's Web whole-plant CBD extracts come in full-spectrum and broad-spectrum options, including ReCreate™ by Charlotte's Web, broad-spectrum CBD certified NSF for Sport®. ReCreate is the official CBD of Major League Baseball©, Angel City Football Club and the Premier Lacrosse League. Charlotte's Web branded premium quality products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company's hemp extracts have naturally occurring botanical compounds including cannabidiol ("CBD"), CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products) CBD gummies (sleep, calming, exercise recovery, immunity), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs.  Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte's Web products are distributed to retailers and health care practitioners throughout the U.S.A, and online through the Company's website at www.charlottesweb.com.  

    Shares of Charlotte's Web trade on the Toronto Stock Exchange (TSX) under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF".

    Subscribe to Charlotte's Web investor news.

    © Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

     

    Forward-Looking Information 

    Certain information in this news release constitutes forward-looking statements and forward-looking information within the meaning of applicable securities laws (collectively, "forward-looking information"). In some cases, but not necessarily in all cases, forward looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information.

    Statements containing forward-looking information are not historical facts, but instead represent management's current expectations, estimates and projections regarding the future of our business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such statements containing forward-looking information. Although these statements containing forward-looking information are based on assumptions the Company considers to be reasonable based on the information available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking information.

    The material factors and assumptions used to develop the forward-looking information herein include, but are not limited to, international and political considerations; regulatory changes; and the factors discussed throughout the "Risk Factors" section of the Company's most recently filed annual information form available on www.SEDAR.com and in the Company's most recently filed Annual Report on Form 10-K and quarterly report on Form 10-Q as amended, and other filings with the Securities and Exchange Commission available on www.SEC.gov. Except as required by applicable securities laws, the Company undertakes no obligation to publicly update any forward-looking information, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

    Charlotte's Web Holdings, Inc. 

    THE WORLD'S MOST TRUSTED HEMP EXTRACT

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-announces-appointment-of-bill-morachnick-as-chief-executive-officer-301926083.html

    SOURCE Charlotte's Web Holdings, Inc.

    Get the next $BTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BTI

    DatePrice TargetRatingAnalyst
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    11/1/2023$38.00Overweight
    Morgan Stanley
    9/25/2023Buy
    Citigroup
    9/1/2023Buy → Hold
    Argus
    3/13/2023Overweight → Neutral
    JP Morgan
    More analyst ratings

    $BTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on British American Tobacco

      BofA Securities resumed coverage of British American Tobacco with a rating of Buy

      4/30/25 9:01:21 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco upgraded by UBS

      UBS upgraded British American Tobacco from Neutral to Buy

      1/27/25 7:35:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded British American Tobacco from Overweight to Underweight and set a new price target of $33.00

      10/3/24 7:24:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Leadership Updates

    Live Leadership Updates

    See more
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

      Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

      9/13/23 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • GREENBUTTS APPPOINTS FORMER BIG TOBACCO EXECUTIVE AS CHIEF STRATEGY OFFICER

      SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri

      6/22/22 2:34:00 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Financials

    Live finance-specific insights

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 Second Quarter Financial Results

      Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

      8/10/23 7:33:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 First Quarter Financial Results

      Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye

      5/12/23 7:05:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Organigram Announces C$124.6 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool

      Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create "Jupiter," a strategic investment pool designed to expand Organigram's geographic footprint and capitalize on emerging growth opportunities C$41.5 million of the investment will be used for general corporate purposes Investment enhances strategic Product Development Collaboration between BAT and Organigram, which focuses on cutting-edge R&D and product innovation BAT to increase voting Common Share ownership position to 30% and overall equity interest to 45% (including non-voting Class A P

      11/6/23 6:00:00 AM ET
      $BTI
      $OGI
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations

    $BTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Bt De Investments Inc.

      3 - British American Tobacco p.l.c. (0001303523) (Reporting)

      11/23/22 4:29:54 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 6:03:23 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 5:46:32 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      1/26/24 4:56:06 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    $BTI
    SEC Filings

    See more
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/9/25 11:07:44 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/6/25 12:33:01 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/1/25 7:49:52 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care